Monday, March 9, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Leadership Transition Fails to Dampen Tapestry’s Record Run

Dieter Jaworski by Dieter Jaworski
September 21, 2025
in Analysis, Consumer & Luxury, Earnings
0
Tapestry Stock
0
SHARES
121
VIEWS
Share on FacebookShare on Twitter

While luxury conglomerate Tapestry continues its impressive stock market performance, a significant board member has announced his departure. This seemingly negative development masks a compelling success story that continues to energize investors.

Strategic Vision Outshines Board Reshuffle

The company confirmed that long-serving board member John P. Bilbrey will not stand for re-election at the upcoming annual meeting scheduled for November 13, 2025. Tapestry explicitly stated this decision is unrelated to any operational or financial disagreements, suggesting instead a planned transition that aligns with the company’s current positive trajectory.

“Amplify” Initiative Fuels Market Confidence

Investor enthusiasm primarily stems from Tapestry’s recently unveiled “Amplify” growth strategy, presented on September 10, 2025. The ambitious roadmap targets mid-single-digit annual revenue growth and low double-digit increases in adjusted earnings per share through fiscal 2028. The most impactful announcement, however, was the commitment to return $4 billion to shareholders by 2028 through a combination of share repurchases and dividend distributions.

This shareholder-friendly approach was immediately demonstrated through a 14% dividend increase to $0.40 per share, payable on September 22, 2025.

Should investors sell immediately? Or is it worth buying Tapestry?

Wall Street Responds with Upgraded Targets

The strategic direction has garnered strong approval from major financial institutions. Several prominent firms, including JPMorgan, Barclays, and Wells Fargo, have significantly raised their price targets. JPMorgan increased its objective to $142, while Barclays set its target at $127. Analysts express widespread optimism regarding Tapestry’s growth prospects and the enduring strength of its core Coach brand, which is projected to achieve $10 billion in long-term revenue.

Persistent Challenges on the Horizon

Despite the prevailing optimism, Tapestry faces several headwinds. The Kate Spade brand continues to encounter difficulties, though management has committed to achieving a profitable turnaround by 2027. Additionally, the company must navigate an estimated $160 million in U.S. tariffs through 2028.

A more significant concern remains the ongoing legal challenge from the U.S. Federal Trade Commission (FTC), which seeks to block Tapestry’s $8.5 billion acquisition of Capri Holdings. This litigation has been underway since September 2024.

Market Performance and Future Prospects

Tapestry’s shares ended Friday’s trading session just marginally below their all-time high of €97.05, reflecting a remarkable year-to-date gain of 51.74%. All focus now shifts to the successful execution of the “Amplify” strategy. The upcoming November shareholder meeting represents the next key milestone. Whether Tapestry can sustain its record-breaking performance hinges entirely on converting its ambitious targets into tangible financial results.

Ad

Tapestry Stock: Buy or Sell?! New Tapestry Analysis from March 9 delivers the answer:

The latest Tapestry figures speak for themselves: Urgent action needed for Tapestry investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 9.

Tapestry: Buy or sell? Read more here...

Tags: Tapestry
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Sangamo Therapeutics Stock
Analysis

Sangamo Therapeutics: Regulatory and Financial Milestones Converge

March 9, 2026
Outlook Therapeutics Stock
Analysis

Outlook Therapeutics: Navigating the Final Stretch to Commercialization

March 9, 2026
Lumentum Stock
AI & Quantum Computing

Lumentum’s Path to Growth Hinges on Manufacturing Scale

March 9, 2026
Next Post
Clearpointeuro Stock

Institutional Confidence in ClearPoint Neuro Remains Strong Despite Share Price Dip

Preformed Line Products Stock

A Dividend Powerhouse in Infrastructure's Quiet Corner

N-Able Stock

N-Able Shares Face Market Skepticism Despite Strong Cybersecurity Fundamentals

Recommended

Biotechnology Stock Bull Market

Novavax Implements Major Changes to Operations and Finances in Response to Market Conditions

2 years ago
Lockheed Stock

Lockheed Martin Forges AI Alliance with Google Amid Stock Market Paradox

4 months ago
Technology Quantum computing Market Capitalization

Stifel Analyst Maintains Buy Rating on Adobe with Lowered Price Target

2 years ago
Coca-Cola Stock

Coca-Cola Shares Under Scrutiny as Executives Sell Holdings

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Block’s Strategic Pivot: AI and Efficiency Drive 2026 Transformation

A Pivotal Period for Porsche Holding Investors

AI Firm Anthropic Challenges Pentagon’s Security Risk Designation

Fiserv’s Strategic Overhaul: A Bid to Regain Investor Confidence

Viking Therapeutics: Investor Focus Shifts to Phase 3 Obesity Program

UnitedHealth Navigates Strategic Overhaul Amid Market Headwinds

Trending

Sangamo Therapeutics Stock
Analysis

Sangamo Therapeutics: Regulatory and Financial Milestones Converge

by Kennethcix
March 9, 2026
0

Investor attention is firmly fixed on Sangamo Therapeutics as the company approaches several pivotal near-term events. The...

Outlook Therapeutics Stock

Outlook Therapeutics: Navigating the Final Stretch to Commercialization

March 9, 2026
Lumentum Stock

Lumentum’s Path to Growth Hinges on Manufacturing Scale

March 9, 2026
Block Stock

Block’s Strategic Pivot: AI and Efficiency Drive 2026 Transformation

March 9, 2026
Porsche Holding Stock

A Pivotal Period for Porsche Holding Investors

March 9, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Sangamo Therapeutics: Regulatory and Financial Milestones Converge
  • Outlook Therapeutics: Navigating the Final Stretch to Commercialization
  • Lumentum’s Path to Growth Hinges on Manufacturing Scale

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com